Home » Stocks » EKSO

Ekso Bionics Holdings, Inc. (EKSO)

Stock Price: $8.85 USD 0.17 (1.96%)
Updated Jan 20, 2021 4:00 PM EST - Market closed
After-hours: $8.95 +0.10 (1.13%) Jan 20, 5:56 PM
Market Cap 74.10M
Revenue (ttm) 10.35M
Net Income (ttm) -14.57M
Shares Out 8.24M
EPS (ttm) -2.35
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 20
Last Price $8.85
Previous Close $8.68
Change ($) 0.17
Change (%) 1.96%
Day's Open 8.80
Day's Range 8.46 - 9.14
Day's Volume 244,971
52-Week Range 2.54 - 9.23

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
GlobeNewsWire - 1 week ago

RICHMOND, Calif., Jan. 13, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced pre...

GlobeNewsWire - 3 weeks ago

RICHMOND, Calif., Dec. 30, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, tod...

GlobeNewsWire - 2 months ago

RICHMOND, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, tod...

Seeking Alpha - 2 months ago

Ekso Bionics Holdings, Inc. (EKSO) CEO Jack Peurach on Q3 2020 Results - Earnings Call Transcript

GlobeNewsWire - 2 months ago

RICHMOND, Calif., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, tod...

GlobeNewsWire - 2 months ago

A c utting-edge endurance-boosting assistive device , E VO is designed to reduce the risk of repetitive or fatigue-related injuries for construction workers and other industrial employees

GlobeNewsWire - 2 months ago

RICHMOND, Calif., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced tha...

GlobeNewsWire - 4 months ago

RICHMOND, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced ...

GlobeNewsWire - 5 months ago

RICHMOND, Calif., Aug. 20, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”) , an industry leader in exoskeleton technology for medical and industrial use...

Seeking Alpha - 5 months ago

Ekso Bionics Holdings, Inc. (EKSO) CEO Jack Peurach on Q2 2020 Results - Earnings Call Transcript

Zacks Investment Research - 5 months ago

Ekso Bionics (EKSO) delivered earnings and revenue surprises of 0.00% and 22.38%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research - 5 months ago

Ekso Bionics (EKSO) Q2 earnings are expected to have been boosted by its recent efforts to grow virtual connectivity with customers and to reduce costs.

GlobeNewsWire - 5 months ago

RICHMOND, Calif., July 23, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced t...

GlobeNewsWire - 6 months ago

WASHINGTON and RICHMOND, Calif., July 09, 2020 (GLOBE NEWSWIRE) -- The Army Distaff Foundation (ADF) , a non-profit charity in Washington, D.C., which operates Knollwood Military Life Plan ...

Benzinga - 6 months ago

Ekso Bionics Holdings (NASDAQ: EKSO) shares were trading higher Friday on continued strength after the company received FDA clearance to market its EksoNR robotic exoskeleton.

InvestorPlace - 6 months ago

Ekso Bionics (EKSO) news for Thursday concerning approval from the FDA for one of its devices has EKSO stock soaring higher.

Market Watch - 6 months ago

Shares of Ekso Bionics Holdings Inc. EKSO, 130.85% soared Thursday, after the company said it has received 501 clearance from the U.S. Food and Drug Administration to market its EksoNR robotic...

GlobeNewsWire - 6 months ago

RICHMOND, Calif., June 25, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”) , an industry leader in exoskeleton technology for medical and industrial use,...

Zacks Investment Research - 7 months ago

Ekso Bionics (EKSO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

GlobeNewsWire - 7 months ago

RICHMOND, Calif., June 10, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, t...

GlobeNewsWire - 7 months ago

RICHMOND, Calif., June 08, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, t...

GlobeNewsWire - 7 months ago

Annual Awards Program Recognizes Outstanding Health & Medical Technology Products and Companies Annual Awards Program Recognizes Outstanding Health & Medical Technology Products and Companies

GlobeNewsWire - 8 months ago

RICHMOND, Calif., May 20, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, to...

GuruFocus - 8 months ago

Wall Street sell-side analysts are positive about Ekso Bionics Holdings Inc (NASDAQ:EKSO) and Entasis Therapeutics Holdings Inc (NASDAQ:ETTX), even though their holdings have lost more than 59...

Other stocks mentioned: ETTX
Seeking Alpha - 8 months ago

Ekso Bionics Holdings, Inc. (EKSO) CEO Jack Peurach on Q1 2020 Results - Earnings Call Transcript

GlobeNewsWire - 9 months ago

- Company Regains Nasdaq Listing Compliance -

GlobeNewsWire - 9 months ago

RICHMOND, Calif., March 24, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (the “Company”) (Nasdaq: EKSO), a leading developer of exoskeletons for medical and industrial use, today ann...

Seeking Alpha - 10 months ago

Ekso Bionics Holdings, Inc. (EKSO) CEO Jack Peurach on Q4 2019 Results - Earnings Call Transcript

GlobeNewsWire - 10 months ago

RICHMOND, Calif., Feb. 25, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), a leading developer of exoskeletons for medical and industrial use, today announced a collabor...

GlobeNewsWire - 1 year ago

RICHMOND, Calif., Dec. 20, 2019 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, t...

GlobeNewsWire - 1 year ago

RICHMOND, Calif., Dec. 20, 2019 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ: EKSO), a leading developer of exoskeletons for medical and industrial use, today announced it signed ...

GlobeNewsWire - 1 year ago

RICHMOND, Calif., Dec. 19, 2019 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, t...

Seeking Alpha - 1 year ago

Ekso Bionics Holdings Inc. (EKSO) CEO Jack Peurach on Q3 2019 Results - Earnings Call Transcript

GlobeNewsWire - 1 year ago

RICHMOND, Calif., Sept. 23, 2019 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), a leading developer of exoskeletons for medical and industrial use, today announced that Jack...

Seeking Alpha - 1 year ago

Ekso Bionics Holdings, Inc. (EKSO) CEO Jack Peurach on Q2 2019 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

Ekso Bionics (EKSO) delivered earnings and revenue surprises of -25.00% and -9.08%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

Seeking Alpha - 1 year ago

Ekso Bionics Holdings, Inc. (EKSO) CEO Jack Peurach on Q1 2019 Results - Earnings Call Transcript

TechCrunch - 2 years ago

Wrapping a Robot Around a Human

Ekso is building robotic exoskeletons for rehab and work -- We pay a visit to Ekso's Bay Area headquarters.

About EKSO

Ekso Bionics Holdings designs, develops, and sells exoskeletons for use in the healthcare, industrial, and military markets in the United States and internationally. The company operates in two segments, EksoHealth and EksoWorks. It primarily offers EksoNR, a bionic suit that provides the ability to stand and walk over ground with a full weight-bearing, reciprocal gait using a cane, crutches, or a walker to individuals with spinal cord injuries and hemiplegia due to stroke; and EksoUE, a wearable assistive device that helps to reduce the effect... [Read more...]

Industry
Medical Instruments & Supplies
Founded
2005
CEO
Jack Peurach
Employees
67
Stock Exchange
NASDAQ
Ticker Symbol
EKSO
Full Company Profile

Financial Performance

In 2019, EKSO's revenue was $13.92 million, an increase of 22.81% compared to the previous year's $11.33 million. Losses were -$12.13 million, -55.05% less than in 2018.

Financial Statements

Analyst Forecasts

According to 2 analysts, the average rating for EKSO stock is "Buy." The 12-month stock price forecast is 10.00, which is an increase of 12.99% from the latest price.

Price Target
$10.00
(12.99% upside)
Analyst Consensus: Buy